Vimarsana
Biggest News Aggregation in the World

Page 26 - Ps Estimates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ps Estimates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ps Estimates Today - Breaking & Trending Today

Apyx Medical (APYX) Reports Q2 Loss, Misses Revenue Estimates - Vimarsana News

Apyx Medical (APYX) Reports Q2 Loss, Misses Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 8.33% and 4.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Source: yahoo.com
Markforged Holding Corporation (MKFG) Reports Q2 Loss, Tops Revenue Estimates - Vimarsana News

Markforged Holding Corporation (MKFG) Reports Q2 Loss, Tops Revenue Estimates

Markforged Holding Corporation (MKFG) delivered earnings and revenue surprises of 0% and 5.42%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Source: yahoo.com
Onto Innovation (ONTO) Lags Q2 Earnings and Revenue Estimates - Vimarsana News

Onto Innovation (ONTO) Lags Q2 Earnings and Revenue Estimates

Onto Innovation (ONTO) delivered earnings and revenue surprises of -4.82% and 6.08%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Source: yahoo.com
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates - Vimarsana News

Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of -54.55% and 9.66%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Source: yahoo.com
Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates - Vimarsana News

Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -37.78% and 6.81%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Source: yahoo.com